Nonsteroidal Anti-inflammatory Drugs Sensitize CD44-Overexpressing Cancer Cells to Hsp90 Inhibitor Through Autophagy Activation

Recently, novel therapeutic strategies have been designed with the aim of killing cancer stem-like cells (CSCs), and considerable interest has been generated in the development of specific therapies that target stemness-related marker of CSCs. In this study, nonsteroidal anti-inflammatory drugs (NSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Hyun-Jung, Park, So-Young, Lee, Su-Hoon, Kang, Chi-Dug, Kim, Sun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848457/
https://www.ncbi.nlm.nih.gov/pubmed/30982499
http://dx.doi.org/10.3727/096504019X15517850319579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848457/
https://www.ncbi.nlm.nih.gov/pubmed/30982499
http://dx.doi.org/10.3727/096504019X15517850319579

Ejemplares similares